Thiola EC 100 MG tablet 300S
Ended Awarded Last action
- Contract number
- SPE2DR26FMEB3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,275
Award facts
- Contract value 100% obligated
- $37,275.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,275.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Thiola EC 100 mg tablets (300-count units). The award, issued on December 9, 2025, with an ultimate completion date of December 31, 2025, was made without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy, which establishes multiple regional prime vendor contractors to support recurring medical supply needs of military healthcare facilities worldwide. The company's established performance across numerous delivery orders—ranging from small purchases under $100 to significant awards exceeding $115,000—demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of Department of Defense healthcare operations. The delivery order for Thiola EC represents a routine pharmaceutical procurement supporting the federal military medical system's therapeutic needs.
Quick answers
Who was awarded contract SPE2DR26FMEB3?
SPE2DR26FMEB3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FMEB3 worth?
The government has obligated $37,275 on SPE2DR26FMEB3.
Is contract SPE2DR26FMEB3 an order under another contract?
Yes. SPE2DR26FMEB3 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEB3 competed?
The extent of competition for SPE2DR26FMEB3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award